gene and myocardial infarction, which is different from our meta-analysis. And also we analyzed the heterogeneity in the Discussion section in our meta-analysis.
Taking these into account, we have now performed a new analysis by adding the five studies. [3] [4] [5] [6] 18 The pooled results showed that the MTHFR C677T polymorphism was significantly associated with PE (P ¼ 0.01, odds ratio (OR) ¼ 1.26, 95% confidence interval (CI) ¼ 1.04-1.52, P heterogeneity ¼ 0.03, for the dominant genetic model; P ¼ 0.02, OR ¼ 1.26, 95% CI ¼ 1.04-1.52, P heterogeneity ¼ 0.001, for the recessive genetic model; P ¼ 0.004, OR ¼ 1.34, 95% CI ¼ 1.10-1.64, P heterogeneity ¼ 0.007, for the additive genetic model). The results of the subgroup analysis showed that MTHFR 677T had the effect of increasing the PE risk for the recessive genetic model (Po0.0001, OR ¼ 2.15, 95% CI ¼ 1.66-2.80, P heterogeneity ¼ 0.16), the additive comparison (Po0.0001, OR ¼ 2.56, 95% CI ¼ 1.88-3.47, P heterogeneity ¼ 0.24) and allele contrasts (Po0.0001, OR ¼ 1.52, 95% CI ¼ 1.31-1.77, P heterogeneity ¼ 0.13) in the Asian population, whereas there was no evidence of an association between MTHFR C677T polymorphisms and PE observed in Caucasians.
The conclusion from this new analysis agrees with that of our previous study. 2 In summary, the constructive comments provided help to our study to reach more persuasive conclusions.
